Skip to main content

Andreessen Marc L's Form 4 filing

Camp4 Therapeutics Corp (CAMP) · filed Oct 17, 2024

Accession no.
0001415889-24-025380
Filed
Oct 17, 2024, 5:05 PM ET
Trade date
Oct 15, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $8.00M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Andreessen Marc LCIK 000116007710% Owner
Horowitz Benjamin ACIK 000116658610% Owner
AH Equity Partners Bio I, L.L.C.CIK 000165662610% Owner
AH Bio Fund I, L.P.CIK 000165662910% Owner
AH Bio Fund IV, L.P.CIK 000188947610% Owner
AH Equity Partners Bio IV, L.L.C.CIK 000188989810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 15, 2024Common StockCConversionAcquired+1,398,067––1,398,067Indirect
Oct 15, 2024Common StockPPurchaseAcquired+181,818$11.00+$1,999,9981,579,885Indirect
Oct 15, 2024Common StockPPurchaseAcquired+545,454$11.00+$5,999,994545,454Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 15, 2024Common StockCConversionDisposed−1,337,513––0Indirect
Oct 15, 2024Common StockCConversionDisposed−60,554––0Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)